BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9700507)

  • 1. Antigen-presenting function of mouse CD1: one molecule with two different kinds of antigenic ligands.
    Brossay L; Burdin N; Tangri S; Kronenberg M
    Immunol Rev; 1998 Jun; 163():139-50. PubMed ID: 9700507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.
    Burdin N; Brossay L; Koezuka Y; Smiley ST; Grusby MJ; Gui M; Taniguchi M; Hayakawa K; Kronenberg M
    J Immunol; 1998 Oct; 161(7):3271-81. PubMed ID: 9759842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-presenting function of the TL antigen and mouse CD1 molecules.
    Cheroutre H; Holcombe HR; Tangri S; Castaño AR; Teitell M; Miller JE; Cardell S; Benoist C; Mathis D; Huse WD
    Immunol Rev; 1995 Oct; 147():31-52. PubMed ID: 8847078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-presenting function of the mouse CD1 molecule.
    Tangri S; Holcombe HR; Castaño AR; Miller JE; Teitell M; Huse WE; Peterson PA; Kronenberg M
    Ann N Y Acad Sci; 1996 Feb; 778():288-96. PubMed ID: 8610982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse CD1 is mainly expressed on hemopoietic-derived cells.
    Brossay L; Jullien D; Cardell S; Sydora BC; Burdin N; Modlin RL; Kronenberg M
    J Immunol; 1997 Aug; 159(3):1216-24. PubMed ID: 9233616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse CD1-autoreactive T cells have diverse patterns of reactivity to CD1+ targets.
    Brossay L; Tangri S; Bix M; Cardell S; Locksley R; Kronenberg M
    J Immunol; 1998 Apr; 160(8):3681-8. PubMed ID: 9558068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of peptide antigens by mouse CD1 requires endosomal localization and protein antigen processing.
    Tangri S; Brossay L; Burdin N; Lee DJ; Corr M; Kronenberg M
    Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14314-9. PubMed ID: 9826697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural requirements for antigen presentation by mouse CD1.
    Burdin N; Brossay L; Degano M; Iijima H; Gui M; Wilson IA; Kronenberg M
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10156-61. PubMed ID: 10963678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells.
    Brossay L; Naidenko O; Burdin N; Matsuda J; Sakai T; Kronenberg M
    J Immunol; 1998 Nov; 161(10):5124-8. PubMed ID: 9820479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonclassical behavior of the mouse CD1 class I-like molecule.
    Teitell M; Holcombe HR; Brossay L; Hagenbaugh A; Jackson MJ; Pond L; Balk SP; Terhorst C; Peterson PA; Kronenberg M
    J Immunol; 1997 Mar; 158(5):2143-9. PubMed ID: 9036959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide binding and presentation by mouse CD1.
    Castaño AR; Tangri S; Miller JE; Holcombe HR; Jackson MR; Huse WD; Kronenberg M; Peterson PA
    Science; 1995 Jul; 269(5221):223-6. PubMed ID: 7542403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen specificity of semi-invariant CD1d-restricted T cell receptors: the best of both worlds?
    Gumperz JE
    Immunol Cell Biol; 2004 Jun; 82(3):285-94. PubMed ID: 15186260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Third Way: Progress on pathways of antigen processing and presentation by CD1.
    Lawton AP; Kronenberg M
    Immunol Cell Biol; 2004 Jun; 82(3):295-306. PubMed ID: 15186261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipids hide or step aside for CD1-autoreactive T cell receptors.
    Cotton RN; Shahine A; Rossjohn J; Moody DB
    Curr Opin Immunol; 2018 Jun; 52():93-99. PubMed ID: 29738961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of human T cells by CD1 and self-lipids.
    de Jong A
    Immunol Rev; 2015 Sep; 267(1):16-29. PubMed ID: 26284469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of an antigen-specific, CD1-restricted cytotoxic T lymphocyte response In vivo.
    Lee DJ; Abeyratne A; Carson DA; Corr M
    J Exp Med; 1998 Feb; 187(3):433-8. PubMed ID: 9449723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells.
    van de Wal Y; Corazza N; Allez M; Mayer LF; Iijima H; Ryan M; Cornwall S; Kaiserlian D; Hershberg R; Koezuka Y; Colgan SP; Blumberg RS
    Gastroenterology; 2003 May; 124(5):1420-31. PubMed ID: 12730881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The versatility of the CD1 lipid antigen presentation pathway.
    Chancellor A; Gadola SD; Mansour S
    Immunology; 2018 Jun; 154(2):196-203. PubMed ID: 29460282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD1--a new paradigm for antigen presentation and T cell activation.
    Sugita M; Moody DB; Jackman RM; Grant EP; Rosat JP; Behar SM; Peters PJ; Porcelli SA; Brenner MB
    Clin Immunol Immunopathol; 1998 Apr; 87(1):8-14. PubMed ID: 9576005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surprisingly minor influence of TRAV11 (Valpha14) polymorphism on NK T-receptor mCD1/alpha-galactosylceramide binding kinetics.
    Sim BC; Holmberg K; Sidobre S; Naidenko O; Niederberger N; Marine SD; Kronenberg M; Gascoigne NR
    Immunogenetics; 2003 Mar; 54(12):874-83. PubMed ID: 12671739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.